Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery - 1 Nov 2020

Jünger Stephanie T, Andreiuolo Felipe, Mynarek Martin, Dörner Evelyn, Zur Mühlen Anja, Rutkowski Stefan, von Bueren Andre O, Pietsch Torsten

Abstract excerpt

INTRODUCTION: Young age is an adverse prognostic factor in children with ependymomas. Treatment of these infants is challenging since beneficial therapeutic options are limited. As ependymomas are considered a biologically heterogeneous group, we aimed to characterize infant ependymomas with regard to their histological and genetic features. MATERIALS AND METHODS: We analyzed 28 ependymomas occurring in children...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ependymoma

Share to Infant

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 32474813
DOI: 10.1007/s00381-020-04655-x
PMCID: PMC7575464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.PMID 32474813Read ↗

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsSemantic proximity Read ↗

Supratentorial ependymoma in childhood: more than just RELA or YAPSemantic proximity Read ↗

Pediatric Ependymoma: Biological PerspectivesSemantic proximity Read ↗

Intracranial ependymomas: molecular insights and translation to treatmentSemantic proximity Read ↗

Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.Semantic proximity Read ↗

Recurrent fusions in <i>PLAGL1</i> define a distinct subset of pediatric-type supratentorial ependymomaSemantic proximity Read ↗

Pediatric Brain TumorsSemantic proximity Read ↗

Emerging Insights into the Ependymoma EpigenomeSemantic proximity Read ↗

Molecular genetics of ependymomaSemantic proximity Read ↗

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.Semantic proximity Read ↗

Advances in the classification and treatment of pediatric brain tumors.Semantic proximity Read ↗

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.